Cassiopea SpA: Clinical Trials

7 completed. 5 Phase 3, 1 Phase 1, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	5	Completed 5
Phase 1	1	Completed 1
Phase 2	1	Completed 1

Follow Cassiopea SpA: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2) Clascoterone 5% solution, Vehicle solution - Alopecia, Androgenetic	Phase 3	Completed	Cassiopea SpA	762	2023-08-17	2025-12-22
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss Clascoterone 5% solution, Vehicle solution - Alopecia, Androgenetic	Phase 3	Completed	Cassiopea SpA	703	2023-06-21	2026-06-08
A Study to Investigate the Effects of Cortexolone 17α-propionate (and Its Metabolites) on Healthy Volunteers' Heart Cortexolone 17α-propionate solution, Placebo - Healthy Volunteers	Phase 1	Completed	Cassiopea SpA	32	2018-06-06	2019-02-04
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris cortexolone 17α-propionate - Acne Vulgaris	Phase 2	Completed	Cassiopea SpA	27	2016-10-28	2020-11-20
An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris CB-03-01 cream, 1% - Acne Vulgaris	Phase 3	Completed	Cassiopea SpA	609	2016-03-09	2020-11-17
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) CB-03-01 cream, 1%, Vehicle cream - Acne Vulgaris	Phase 3	Completed	Cassiopea SpA	708	2016-01-21	2020-11-20
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) CB-03-01 cream, 1%, Vehicle cream - Acne Vulgaris	Phase 3	Completed	Cassiopea SpA	732	2015-11-16	2020-11-20

Conditions studied

Acne Vulgaris (4)  ·  Alopecia (2)

Interventions

Clascoterone (6)  ·  Solutions (2)

Countries

United States (6)  ·  Georgia (4)  ·  Poland (4)  ·  Bulgaria (2)  ·  Romania (2)  ·  Serbia (2)  ·  Ukraine (2)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Alessandro Mazzetti, M.D. (2)  ·  Jorg Taubel, MD FFPM (1)

Results publications

PMID 32320027, PMID 34607697, PMID 36745367, PMID 38206145